Retraction to ‘DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP’

Código QR

Retraction to ‘DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP’

Guardado en:

Detalles Bibliográficos
Autores principales:	Ronghua Liu, Yucan Zhang, Peiwen Sun, Changxiu Wang
Formato:	article
Lenguaje:	EN
Publicado:	The Royal Society 2021
Materias:	Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/6c85934e71e8447fb16ad6b31acf683d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells
por: Zhi Jiang, et al.
Publicado: (2009)

MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy
por: Yi Cai, et al.
Publicado: (2021)

Vildagliptin: the first innovative DDP-4 inhibitor
por: Edvin Villkhauer
Publicado: (2010)

Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4 nanoparticles in A549/DDP lung cancer cells in vitro and in vivo
por: Li K, et al.
Publicado: (2013)

Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment
por: Jing Du, et al.
Publicado: (2017)

MicroRNA characteristics in epithelial ovarian cancer.
por: Kira Philipsen Prahm, et al.
Publicado: (2021)

Silmitasertib-induced macropinocytosis promoting DDP intracellular uptake to enhance cell apoptosis in oral squamous cell carcinoma
por: Shaojuan Song, et al.
Publicado: (2021)

On the reproducibility of TCGA ovarian cancer microRNA profiles.
por: Ying-Wooi Wan, et al.
Publicado: (2014)

Biodegradable thermosensitive hydrogel for SAHA and DDP delivery: therapeutic effects on oral squamous cell carcinoma xenografts.
por: Jing Li, et al.
Publicado: (2012)

Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer
por: Mohamed K. Hassan, et al.
Publicado: (2021)

Integrated extracellular microRNA profiling for ovarian cancer screening
por: Akira Yokoi, et al.
Publicado: (2018)

GraphDDP: a graph-embedding approach to detect differentiation pathways in single-cell-data using prior class knowledge
por: Fabrizio Costa, et al.
Publicado: (2018)

MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2
por: Xie,Hui Hui, et al.
Publicado: (2019)

Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
por: D. M. Janzen, et al.
Publicado: (2020)

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
por: Chi Lam Au Yeung, et al.
Publicado: (2016)

nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer
por: Ji-Hye Ahn, et al.
Publicado: (2018)

Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells
por: Maura Sonego, et al.
Publicado: (2017)

Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines
por: Viscarra,Tamara, et al.
Publicado: (2019)

Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer
por: Lucía Pascual-Antón, et al.
Publicado: (2021)

Prediction of Key Candidate Genes for Platinum Resistance in Ovarian Cancer
por: Guo K, et al.
Publicado: (2021)

Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer.
por: Joanna Lopacinska-Jørgensen, et al.
Publicado: (2021)

MicroRNA genes and their target 3'-untranslated regions are infrequently somatically mutated in ovarian cancers.
por: Georgina L Ryland, et al.
Publicado: (2012)

The mTORC2 component rictor contributes to cisplatin resistance in human ovarian cancer cells.
por: Akechai Im-aram, et al.
Publicado: (2013)

NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines
por: North WG, et al.
Publicado: (2015)

Emerging Functions and Clinical Applications of Exosomal ncRNAs in Ovarian Cancer
por: Yu Zhang, et al.
Publicado: (2021)

Author Correction: nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer
por: Ji-Hye Ahn, et al.
Publicado: (2018)

Investigation of energy metabolic dynamism in hyperthermia-resistant ovarian and uterine cancer cells under heat stress
por: Taisei Kanamori, et al.
Publicado: (2021)

The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer.
por: Wei Wu, et al.
Publicado: (2014)

DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer
por: Riikka J. Lund, et al.
Publicado: (2017)

Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway
por: Lu Jiang, et al.
Publicado: (2021)

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Sajad Dar, et al.
Publicado: (2017)

Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy
por: Alessandra Ferraresi, et al.
Publicado: (2021)

Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer.
por: J Robert McCorkle, et al.
Publicado: (2021)

Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.
por: Christine S Walsh, et al.
Publicado: (2021)

Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
por: Melayshia McFadden, et al.
Publicado: (2021)

Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
por: Mee Young Kim, et al.
Publicado: (2021)

C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
por: Dan Liu, et al.
Publicado: (2018)

Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cell.
por: Wei Yu, et al.
Publicado: (2011)

Avaliação de políticas públicas: uma abordagem DDP aplicada ao programa de incentivo fiscal "produzir" no estado de Goiás (2000-2017)
por: Cleuler Barbosa das Neves, et al.
Publicado: (2020)

Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancer
por: Ryusuke Murakami, et al.
Publicado: (2021)